日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial

绝经前乳腺癌中孕激素受体(PR)肿瘤内异质性:一项随机试验的二次分析

Danielsson, Oscar; Dar, Huma; Perez-Tenorio, Gizeh; Nordenskjöld, Anna; Yau, Christina; Benz, Christopher C; Esserman, Laura J; Nordenskjöld, Bo; Stål, Olle; Fornander, Tommy; Hartman, Johan; Tobin, Nicholas P; Johansson, Annelie; Lindström, Linda S

Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial

绝经状态对乳腺癌患者长期他莫昔芬治疗获益的影响存在差异:一项随机对照临床试验的二次分析

Johansson, Annelie; Dar, Huma; Nordenskjöld, Anna; Perez-Tenorio, Gizeh; Tobin, Nicholas P; Yau, Christina; Benz, Christopher C; Esserman, Laura J; van 't Veer, Laura J; Nordenskjöld, Bo; Stål, Olle; Fornander, Tommy; Lindström, Linda S

GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer

GATA3 和上皮-间质转化标志物可预测 ER 阳性乳腺癌患者从他莫昔芬治疗中获得的长期疗效

Sandström, Josefine; Bomanson, Jens; Pérez-Tenorio, Gizeh; Jönsson, Carolin; Nordenskjöld, Bo; Fornander, Tommy; Lindström, Linda S; Stål, Olle

Pampean megamammals in Europe: the fossil collections from Santiago Roth

欧洲的潘帕斯巨型哺乳动物:圣地亚哥·罗斯的化石收藏

Voglino, Damián; Carrillo-Briceño, Jorge D; Furrer, Heinz; Balcarcel, Ana; Rangel-de Lazaro, Gizeh; Aguirre Fernández, Gabriel; Forasiepi, Analía M

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial

一项对照随机临床试验显示,绝经前乳腺癌患者接受戈舍瑞林和他莫昔芬辅助治疗20年后获益

Johansson, Annelie; Dar, Huma; van 't Veer, Laura J; Tobin, Nicholas P; Perez-Tenorio, Gizeh; Nordenskjöld, Anna; Johansson, Ulla; Hartman, Johan; Skoog, Lambert; Yau, Christina; Benz, Christopher C; Esserman, Laura J; Stål, Olle; Nordenskjöld, Bo; Fornander, Tommy; Lindström, Linda S

Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2-Negative Postmenopausal Breast Cancer Patients

间质肿瘤浸润淋巴细胞(sTILs)在ER阳性/HER2阴性绝经后乳腺癌患者中的预后和预测意义

Pousette, Jenny; Johansson, Annelie; Jönsson, Carolin; Fornander, Tommy; Lindström, Linda S; Olsson, Hans; Perez-Tenorio, Gizeh

Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial

对接受和未接受他莫昔芬治疗的雌激素受体阳性/ERBB2阴性乳腺癌女性患者25年生存率的评估:斯德哥尔摩他莫昔芬随机临床试验数据的二次分析

Dar, Huma; Johansson, Annelie; Nordenskjöld, Anna; Iftimi, Adina; Yau, Christina; Perez-Tenorio, Gizeh; Benz, Christopher; Nordenskjöld, Bo; Stål, Olle; Esserman, Laura J; Fornander, Tommy; Lindström, Linda S

IP6K2 predicts favorable clinical outcome of primary breast cancer

IP6K2 可预测原发性乳腺癌的良好临床结果

Josefine Sandström, Alien Balian, Rebecca Lockowandt, Tommy Fornander, Bo Nordenskjöld, Linda Lindström, Gizeh Pérez-Tenorio, Olle Stål

Ephrin‑B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis‑free survival in breast cancer

Ephrin-B2 可抑制体外细胞增殖和迁移,并预测乳腺癌无转移生存期更长

Zeljana Magic, Josefine Sandström, Gizeh Perez-Tenorio

The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype

PTPN2 缺失对乳腺癌亚型细胞信号传导和临床结果的影响

Cynthia Veenstra, Elin Karlsson, Sanam Mirwani Mirwani, Bo Nordenskjöld, Tommy Fornander, Gizeh Pérez-Tenorio, Olle Stål